CEREBRAL BLOOD FLOW IN WOMEN WITH PRIMARY HEADACHES AND ANTIPHOSPHOLIPID SYNDROME


Cite item

Full Text

Abstract

20 patients with headache (migraine - 7, tension headache -13) associated with hypercoagulable syndrome and 20 healthy women were screened. All patients underwent neurological and transcranialdoppler ultrasonography examinations. Transcranial Doppler ultrasonography measured increased parameters of cerebral blood flow in all patients with a headache associated with hypercoagulable syndrome. All the parameters were higher in elderly patients with primary antiphosholipid syndrome. A significant correlation between patient’s age and blood flow was found.

About the authors

Dina D Gaynetdinova

Kazan State Medical University

Department of Neurology, Neurosurgery and Medical genetics 420012, Kazan, Butlerov str., 49

Saniya I Tukhfatullina

Kazan State Medical University

Email: sonchik-525@yandex.ru
Department of Neurology, Neurosurgery and Medical genetics 420012, Kazan, Butlerov str., 49

References

  1. Калашникова Л.А. Неишемические неврологические проявления у пациентов с первичным антифосфолипидным синдромом // Журнал неврологии и психиатрии им. Корсакова. 2005. № 105. С. 18-23.
  2. Лелюк В.Г., Лелюк С.Е. Ультразвуковая ангиология. М: Реальное время, 2003.
  3. Медик В.А., М.С. Токмачев. Математическая статистика в медицине. М.: Финансы и статистика, 2007.
  4. Насонов Е.Л. Антифосфолипидный синдром. М.,2004.
  5. Пономарева Е.Н., Синевич П.А., Пономарев В.В., А.И. Антоненко. Неврологические нарушения при антифосфолипидном синдроме // Неврологический журнал.2002. № 2. С. 22-24.
  6. Archana D., Manish B., Bhavna S. Headache in pregnancy: a nuisance or a new sense? // Obstet. Gynecol. Int.2012. doi: 10.1155/2012/697697. http://www.hindawi.com/journals/ogi/2012/697697/ (дата обращения: 01.12.14).
  7. Broder A., Tobin JN., Putterman C. High antiphospholipid antibody levels are associated with statin use and may reflect chronic endothelial damage in non-autoimmune thrombosis: cross-sectional study // Clin Pathol. 2012. № 65(6). Р. 551-556.
  8. Carecchio M., Cantello R., Comi C. Revisiting the Molecular Mechanism of Neurological Manifestations in Antiphospholipid Syndrome: Beyond Vascular Damage // J. Immunol. Res. 2014. http://www.hindawi.com/journals/ gir/2014/239398/ (дата обращения: 01.12.14).
  9. Gupta S., Zivadinov R., Ramasamy D., Ambrus J.L Jr. Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature // Clin Rheumatology. 2014. Dec., № 33(12). Р. 1829-1833.
  10. Hughes, G. Migraine, memory loss, and «multiple sclerosis». Neurological features of the antiphospholipid (Hughes’) syndrome // Postgrad Med J. 2003. Vol. 79, № 928. Р. 81-83.
  11. Meroni P.L., Raschi E., Testoni C. Endothelium as a target for antiphospholipid antibodies and for therapeutical intervention // Autoimmun Rev. 2002. № 1(1-2). Р. 55-60.
  12. Nakashima M.O., Rogers H.J. Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants // Blood Res. 2014. Vol. 49, N 2. Р. 85-94.
  13. Rand JH. The antiphospholipid syndrome // HematologyAm Soc Hematol Educ Program. 2007. № 1. P. 136-142.
  14. The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review/ S.Sciascia[et al.] // Ann Rheum Dis. 2014. Jun., № 18.

Copyright (c) 2016 Gaynetdinova D.D., Tukhfatullina S.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies